# Neurocrine Biosciences Inc: Form 8-K, filed Oct 6, 2023

- Company: [Neurocrine Biosciences Inc](/companies/nbix.md) (CIK 914475)
- Form: 8-K
- Filed: 2023-10-06
- Accepted by EDGAR: Oct 6, 2023, 09:00 ET
- Period: 2023-10-05
- Accession: 0000914475-23-000067
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/914475/000091447523000067/nbix-20231005.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/914475/000091447523000067/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/914475/000091447523000067/nbix-20231005.htm

Filed Oct 6, 2023.
Source: SEC EDGAR, the filing index for accession 0000914475-23-000067. Last ingested by Listed: Nov 5, 2026, 17:26 ET. No prices; not investment advice.